EBITDA

HIMS stock Q1 earnings loss rattled investors on Monday as Hims & Hers Health reported first-quarter results that combined solid revenue growth with a dramatic swing to unprofitability. The stock closed regular trading at $29.14, up 3.08% on the day. However, the mood shifted fast after the earnings release hit. Shares fell 9.75% in after-hours…